Global Brand Lead: Late-Stage Oncology & US Launch

Scorpion Therapeutics; Cambridge (MA); On-site; USD 250,000 - 360,000; Full time

Job summary

Scorpion Therapeutics seeks a Senior global commercial leader for Navtemadlin, a Phase 3 oncology therapeutic, to shape brand strategy and drive market execution.

You will lead integrated marketing planning, translate asset strategies into commercial priorities, and coordinate global, regional, and US teams across Medical, Market Access, Regulatory, and other functions. The role focuses on late-stage oncology and US market success.

Qualifications

• BA/BS in business or life sciences required.
• 15+ years in pharma/biotech with late-stage oncology and US launches.
• Oncology/hematology expertise preferred.
• Ability to lead matrix teams and influence stakeholders.

Responsibilities

• Lead integrated marketing planning and translate asset strategies into commercial priorities.
• Coordinate global, regional, and US cross-functional teams across Medical, Market Access, Regulatory, and more.
• Drive lifecycle management, market insights, and performance metrics to maximize asset value.

Skills

Global leadership

Oncology expertise

Cross-functional

Late-stage oncology

US market launch

Education

BA/BS in business or life sciences

Job description

Scorpion Therapeutics seeks a Senior global commercial leader for Navtemadlin, a Phase 3 oncology therapeutic, to shape brand strategy and drive market execution.

You will lead integrated marketing planning, translate asset strategies into commercial priorities, and coordinate global, regional, and US teams across Medical, Market Access, Regulatory, and other functions. The role focuses on late-stage oncology and US market success.